m6A Ribonucleic Acid Methylation in Fibrotic Diseases of Visceral Organs
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.RNA modifications, specifically N6-methyladenosine (m6A) methylation, are increasingly recognized for their role in visceral organ fibrosis. Targeting these RNA changes offers promising therapeutic avenues for fibrotic diseases.
Area Of Science
- Biochemistry
- Molecular Biology
- Pathology
Background
- Fibrosis involves excessive extracellular matrix deposition, leading to organ damage and failure.
- Effective treatments for fibrotic diseases remain limited, despite evidence of reversibility.
- RNA modifications, particularly N6-methyladenosine (m6A), are crucial regulators of gene expression.
Purpose Of The Study
- To review recent advances in understanding the impact of RNA m6A methylation on visceral organ fibrosis.
- To discuss the therapeutic potential of targeting m6A modifications for fibrotic diseases.
Main Methods
- Literature review of studies investigating RNA m6A modification in fibrotic diseases.
- Analysis of the regulatory roles of m6A 'writers,' 'erasers,' and 'readers' in fibrosis.
- Synthesis of current knowledge on m6A's association with lung, heart, liver, and kidney fibrosis.
Main Results
- m6A modification is implicated in diverse cellular processes and human diseases, including organ fibrosis.
- Evidence links m6A RNA modification to fibrotic conditions in major visceral organs.
- m6A methylation dynamics are tightly associated with the pathogenesis of visceral organ fibrosis.
Conclusions
- RNA m6A modification plays a significant role in the development and progression of visceral organ fibrosis.
- Targeting the m6A epitranscriptomic layer presents a novel therapeutic strategy for treating fibrotic diseases.
- Further research into m6A regulators could unlock new treatments for life-threatening fibrotic conditions.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription...